3 | Immune Checkpoint InhibitorsIBA
12/2023
-
01/2022 |
3 | MicellesIBA
01/2017
-
04/2015 |
2 | AgarIBA
06/2023
-
01/2019 |
2 | dihydrocapsaicinIBA
01/2022
-
01/2021 |
2 | CateninsIBA
01/2022
-
01/2021 |
2 | Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2021
-
01/2021 |
2 | Bromodeoxyuridine (BrdU)IBA
01/2021
-
01/2019 |
2 | fosbretabulin (combretastatin A4)IBA
01/2020
-
01/2019 |
2 | Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020
-
08/2014 |
2 | DNA (Deoxyribonucleic Acid)IBA
01/2020
-
01/2019 |
2 | PorphyrinsIBA
08/2015
-
04/2015 |
1 | Angiogenesis InhibitorsIBA
12/2023 |
1 | gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
10/2023 |
1 | BilirubinIBA
10/2023 |
1 | Dacarbazine (DIC)FDA LinkGeneric
06/2023 |
1 | morusinolIBA
06/2023 |
1 | Proteasome Endopeptidase Complex (Proteasome)IBA
06/2023 |
1 | UbiquitinIBA
06/2023 |
1 | isopreneIBA
06/2023 |
1 | FlavonoidsIBA
06/2023 |
1 | colibactinIBA
01/2023 |
1 | anlotinibIBA
01/2022 |
1 | pembrolizumabIBA
01/2022 |
1 | Albumin-Bound PaclitaxelFDA Link
01/2022 |
1 | gamma Catenin (Plakoglobin)IBA
01/2021 |
1 | Biomarkers (Surrogate Marker)IBA
01/2021 |
1 | COP9 Signalosome ComplexIBA
01/2021 |
1 | 3,3'-diindolylmethane (diindolylmethane)IBA
01/2020 |
1 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2020 |
1 | Contrast MediaIBA
01/2020 |
1 | Circular RNAIBA
01/2020 |
1 | EDDA (NiEDDA)IBA
01/2019 |
1 | Proteins (Proteins, Gene)FDA Link
01/2019 |
1 | dehydrocorydalinIBA
01/2019 |
1 | rheinIBA
01/2019 |
1 | Cyclin D1IBA
01/2019 |
1 | AlkaloidsIBA
01/2019 |
1 | Melanins (Melanin)IBA
01/2018 |
1 | BerberineIBA
01/2018 |
1 | Melanocyte-Stimulating Hormones (MSH)IBA
01/2018 |
1 | Dihydroorotate DehydrogenaseIBA
12/2017 |
1 | Leflunomide (Arava)FDA LinkGeneric
12/2017 |
1 | DisulfidesIBA
01/2017 |
1 | CamptothecinIBA
01/2017 |
1 | LigandsIBA
01/2017 |
1 | Sulfhydryl Compounds (Thiols)IBA
01/2017 |
1 | Photosensitizing Agents (Photosensitizers)IBA
01/2017 |
1 | 2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
01/2017 |
1 | Tigecycline (Tygacil)FDA Link
01/2016 |
1 | Anti-Bacterial Agents (Antibiotics)IBA
01/2016 |
1 | 2,3,5- trichloro- 6- phenyl- (1,4)benzoquinoneIBA
09/2015 |
1 | Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
09/2015 |
1 | Caspase 3 (Caspase-3)IBA
09/2015 |
1 | Phosphates (Orthophosphate)IBA
08/2014 |
1 | Saline SolutionIBA
08/2014 |
1 | Hyaluronic Acid (Hyaluronan)IBA
08/2014 |
1 | graphene oxideIBA
08/2014 |
1 | Ascorbic Acid (Vitamin C)FDA LinkGeneric
03/2014 |
1 | Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2014 |
1 | Mesna (Coenzyme M)FDA LinkGeneric
03/2014 |
1 | Thioctic Acid (Lipoic Acid)IBA
03/2014 |
1 | Peptides (Polypeptides)IBA
01/2014 |
1 | Tetrodotoxin (Tetradotoxin)IBA
01/2014 |
1 | Sodium Channels (Sodium Channel)IBA
01/2014 |
1 | Analgesics (Analgesic Drugs)IBA
01/2014 |
1 | Formaldehyde (Formol)FDA Link
01/2014 |
1 | Morphine (MS Contin)FDA LinkGeneric
01/2014 |
1 | Acetic Acid (Vinegar)FDA LinkGeneric
01/2014 |
1 | Mexiletine (Mexitil)FDA LinkGeneric
01/2014 |